Brian Piper

2021

In 2021, Brian Piper earned a total compensation of $2.9M as Former Chief Financial Officer at Prelude Therapeutics, a 48% increase compared to previous year.

Compensation breakdown

Option Awards$2,518,565
Salary$389,458
Total$2,908,023

Piper received $2.5M in option awards, accounting for 87% of the total pay in 2021.

Piper also received $389.5K in salary.

Rankings

In 2021, Brian Piper's compensation ranked 4,547th out of 12,415 executives tracked by ExecPay. In other words, Piper earned more than 63.4% of executives.

ClassificationRankingPercentile
All
4,547
out of 12,415
63rd
Division
Manufacturing
1,880
out of 5,505
66th
Major group
Chemicals And Allied Products
784
out of 2,375
67th
Industry group
Drugs
698
out of 2,096
67th
Industry
Pharmaceutical Preparations
499
out of 1,546
68th
Source: SEC filing on April 29, 2022.

Piper's colleagues

We found three more compensation records of executives who worked with Brian Piper at Prelude Therapeutics in 2021.

2021

Krishna Vaddi

Prelude Therapeutics

Chief Executive Officer

2021

Peggy Scherle

Prelude Therapeutics

Chief Scientific Officer

2021

Andrew Combs

Prelude Therapeutics

EVP and Head of Chemistry

News

In-depth

You may also like